Riamilovir

CAS No. 123606-06-4

Riamilovir( Triazavirin | 7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one )

Catalog No. M23411 CAS No. 123606-06-4

Riamilovir is a broad-spectrum antiviral drug candidate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 92 In Stock
5MG 129 In Stock
10MG 222 In Stock
25MG 389 In Stock
50MG 575 In Stock
100MG 801 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Riamilovir
  • Note
    Research use only, not for human use.
  • Brief Description
    Riamilovir is a broad-spectrum antiviral drug candidate.
  • Description
    Riamilovir is a broad-spectrum antiviral drug candidate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Triazavirin | 7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    123606-06-4
  • Formula Weight
    228.19
  • Molecular Formula
    C5H4N6O3S?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shahab S , Sheikhi M . Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study[J]. Current Molecular Medicine, 2020.
molnova catalog
related products
  • YM-53403

    YM-53403 is an antiviral activity that effectively inhibits the replication of RSV strains belonging to subgroup A and subgroup B. It can be used to treat respiratory syncytial virus infections.

  • DC 07090

    DC 07090 is a human enterovirus 71 3C protease inhibitor with antiviral activity for the study of nucleic acid virus infections.

  • Azaribine

    Azaribine (2;,3;,5;-Tri-O-acetyl-6-azauridine) is an orotate monophosphate decarboxylase (OMPD) inhibitor with broad-spectrum antiviral activity, inhibiting viral genome replication and gene transcription.Azaribine has been used in the study of Zika virus (ZIKV) infections, and in the study of psoriasis, arthritis and mycosis fungoides.